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1Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United KingdomABSTRACT ATP-sensitive potassium (KATP) channels comprise four pore-forming Kir6.2 subunits and four modulatory sulfo-
nylurea receptor (SUR) subunits. The latter belong to the ATP-binding cassette family of transporters. KATP channels are
inhibited by ATP (or ADP) binding to Kir6.2 and activated by Mg-nucleotide interactions with SUR. This dual regulation enables
the KATP channel to couple the metabolic state of a cell to its electrical excitability and is crucial for the KATP channel’s role in
regulating insulin secretion, cardiac and neuronal excitability, and vascular tone. Here, we review the regulation of the KATP
channel by adenine nucleotides and present an equilibrium allosteric model for nucleotide activation and inhibition. The model
can account for many experimental observations in the literature and provides testable predictions for future experiments.ATP-sensitive potassium (KATP) channels play important
roles in a wide variety of physiological processes, including
hormone secretion, neuronal function, cardiac excitability,
and vascular tone (1). They comprise four Kir6.x (Kir6.1
or Kir6.2) subunits, which form a tetrameric pore, and
four modulatory sulfonylurea receptor (SUR) subunits
(Fig. 1 A). There are two SUR genes, SUR1 and SUR2,
but the latter is differentially spliced to give SUR2A and
SUR2B isoforms. These different SUR isoforms confer
different properties upon Kir6.x.
KATP channels are modulated by numerous ligands,
lipids, and drugs, but their most characteristic property is
that they are regulated by cellular metabolism via changes
in adenine nucleotide concentrations. Intracellular ATP
and ADP cause channel inhibition (by binding to Kir6.x),
whereas MgATP and MgADP stimulate channel activity
by interacting with the nucleotide-binding sites (NBSs) of
SUR (2–5). In addition to conferring sensitivity to Mg-nu-
cleotide activation, SUR enhances the unliganded channel
open probability (Po) and increases the affinity for ATP
block (5). It also endows the channel with sensitivity to ther-
apeutic drugs such as sulfonylureas and K-channel openers,
which inhibit and stimulate channel activity, respectively
(5,6). Sulfonylureas are used to treat type 2 diabetes and
neonatal diabetes (7,8), whereas the K-channel opener nic-
orandil is an antianginal agent (9).
Here, we briefly review our current understanding of
the structure and function of the NBSs of SUR. We also
provide a simple equilibrium model of nucleotide handling
by the KATP complex that can account for most current
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0006-3495/15/12/2452/9Structure of the nucleotide-binding domains
SUR belongs to the ATP-binding cassette (ABC) family of
transporters (10–14). Like other ABC proteins, it consists
of two sets of transmembrane domains (TMD1 and
TMD2), each of which contains six helices, and two cyto-
solic nucleotide-binding domains (NBDs) (Fig. 1 B). SUR
also has an additional N-terminal five transmembrane heli-
ces (TMD0). High-resolution structures of SURs or their
isolated NBDs are not yet available. However, the NBSs
of most ABC proteins feature a common structural fold
(14). These highly conserved motifs adopt a bilobed archi-
tecture (Fig. 2). The larger lobe is a RecA-like domain
that is found in other P-loop ATPases and contains the
Walker A (WA) and B (WB) motifs, and functionally impor-
tant aspartate (D-loop) and histidine (H-loop) residues. The
smaller lobe, known as the a-helical subdomain, contains
the ABC signature sequence (typically LSGGQ) and the
Q-loop. The two lobes of the NBDs associate in an antipar-
allel sandwich dimer to form the two NBSs, each of which
contains the WA and WB motifs of one NBD and the signa-
ture sequence of the other NBD. Thus, NBS1 comprises the
WA and WB motifs of NBD1 and the signature sequence of
NBD2, whereas NBS2 contains the WA and WB motifs of
NBD2 plus the signature sequence of NBD1.
In ABC proteins, the WA (or P-loop) motif is a phosphate-
binding loop that contains a highly conserved lysine, which
coordinates the b and g phosphates of ATP. The WB motif
contains a conserved aspartate residue that coordinates
Mg2þ and is crucial for ATP hydrolysis (14). The D-loop
(containing an SALD motif) is responsible for conforma-
tional changes at the catalytic site that favor ATP hydrolysis
(15). The Q-loop is approximately eight residues long,
with a conserved glutamine that is thought to move into
and out of the active site during the hydrolytic cycle (14).
The Q-loop may also be important for the transmis-
sion of binding/hydrolysis events from the NBDs to the
TMDs (16). The ABC signature sequence is located at thehttp://dx.doi.org/10.1016/j.bpj.2015.10.026
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FIGURE 1 Domain organization of the KATP complex. (A) Hetero-octa-
meric complex of the KATP channel, showing the Kir6.x tetrameric pore
(Kir6.1 or Kir6.2) surrounded by four SUR subunits. (B) Schematic repre-
sentation of Kir6.x and SUR protein topologies, indicating the three hydro-
phobic TMDs (TMD0, TMD1, and TMD2) and the two NBDs (NBD1 and
NBD2) of SUR.
NBDs of SUR1 2453N-terminal end of a long helix that directs the positive end
of its dipole toward the g-phosphate of ATP (14).
SUR contains consensus (NBS2) and degenerate (NBS1)
binding sites, which are so named because of the conserva-
tion of their sequences (or lack of it) compared with other
ABC family members. ATP hydrolysis occurs primarily at
NBS2 (17). The crystal structure of a heterodimeric ABC
transporter (TM287/288) with a consensus and degenerate
site has been solved (18,19). Unlike ABC proteins with
two consensus NBSs (20,21), its NBDs remain in contact
even in the absence of nucleotide. This dimerization is sup-
ported by a hydrogen-bonding network that mainly involves
the D-loop. The D-loops also facilitate cross-communica-
tion between the two NBSs of TM287/288 throughout the
transport cycle. A similar interaction appears to occur in
SUR1, where the D- and H-loops are predicted to participate
in formation of the NBD heterodimer. Point mutations at the
predicted interface have dramatic effects on KATP channel
function (22).
Clearly, a high priority in the field is to obtain an x-ray
structure of the NBSs of SUR. Given that each NBS con-
tains elements of both NBDs, crystallization of single
NBDs is not sufficient. Ideally, the structure of the entire
KATP channel complex would be obtained. However, this
poses a considerable technical challenge. To date, only aNBD1 NBD2
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lished (23); however, its resolution is too low to permit iden-
tification of helices, let alone amino acids.Nucleotide interactions at the NBDs
Binding studies have suggested that in addition to being
structurally distinct, the two NBSs of SUR are functionally
different. Covalent 8-azido-[32P]ATP labeling was used to
explore binding at NBS1 and NBS2 of various SUR sub-
types (17,24). These studies revealed that NBS1 bound
ATP in an Mg2þ-independent fashion, whereas nucleotide
binding at NBS2 required Mg2þ. Furthermore, NBS1 was
radiolabeled regardless of whether the 32P label was on
the a or g phosphate of ATP. Only 8-azido-a-[32P]ATP
labeled NBS2. This suggests that NBS2, but not NBS1,
hydrolyzes ATP. Detailed discussions of experiments that
addressed nucleotide interactions with the NBSs of SUR
can be found elsewhere (25,26).Equilibrium model for KATP channel gating
In spite of the structural complexity of the KATP channel,
with eight subunits and 12 nucleotide-binding sites (one
inhibitory site on each Kir6.x subunit and two stimulatory
sites on each SUR), the main features of nucleotide regula-
tion of the KATP channel can be explained with a simplified
equilibrium gating model (Fig. 3).
Our model, which is based on the gating scheme used by
Horrigan and Aldrich (27) to describe activation of BK
channels, considers the channel complex as three indepen-
dent domains—the pore, the inhibitory site on Kir6.x,
and a stimulatory site on SUR1—in coupled equilibrium
(Fig. 3 A). The pore opens and closes in a concerted step
described by the constant L (where L ¼ [open]/[closed] ¼
(Po/(1  Po)) (28,29). All four inhibitory binding sites on
Kir6.x are treated as a single site, which is in either an in-
hibited nucleotide-bound state or a permissive unbound
state, as described by the affinity constant K1 (K1 ¼ [In-
hibited]/([Permissive][ANP]), where ANP is either ATP orNBD2
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FIGURE 2 Structure of the NBSs. (A) Homology
model of the NBSs of SUR1 based on the hetero-
meric structure of TM287/288 (18). (B) Schematic
representation illustrating the functionally important
regions of the NBSs.
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2454 Vedovato et al.ADP) (30,31). Likewise, all eight SUR NBSs are simplified
as a single domain that exists in an unbound resting state or
in an MgANP-bound active state, where K2 ¼ [Activated]/
([Resting][MgANP]). For the purposes of this model, we
have ignored the effects of PIP2, which have been modeled
elsewhere (32).
The interactions between these domains are described by
three more constants: D, E, and F. D describes the allosteric
interaction between the inhibitory binding site and the pore
domain, and is <1. E describes the interaction between
nucleotide binding at the NBDs and the pore, and is >1.
F describes the direct interaction, if any, between the
NBDs and the inhibitory binding site on Kir6.x. This
scheme expands into the cubic model shown in Fig. 3 B.
To understand the contribution of the different domains to
channel gating, it is necessary to isolate their individual
interactions. The pore domain can be studied alone in the
absence of nucleotide. The intrinsic open probability (i.e.,
the Po in nucleotide-free solution) is ~40% for Kir6.2/
SUR1 channels, but is subject to rundown following patch
excision (33). One can isolate nucleotide inhibition at
Kir6.2 by examining the inhibitory effect of nucleotide
binding in the absence of Mg2þ, because nucleotide acti-
vation requires Mg2þ (2,34). When Mg-nucleotides are
applied to wild-type KATP channels, they elicit a mixture
of inhibition and activation. Thus, to study activation by
itself, it is necessary to remove inhibition. This can be
done by taking advantage of a Kir6.2 mutation (G334D)
that renders Kir6.2 completely insensitive to inhibition by
ATP concentrations up to 10 mM, but has a minimal effect
on Po (33,35,36). When coexpressed with SUR1, Kir6.2-
G334D enables Mg-nucleotide activation to be measured
directly (33).
We used the equilibrium binding scheme to fit (solid
lines, Fig. 3 C) macroscopic data from Proks et al. (33).
By first considering data in which nucleotides caused only
activation (Kir6.2-G334D/SUR1 channels) or only inhibi-
tion (wild-type channels in Mg-free solution), we were
able to greatly simplify the model. We made the assumption
that the Kir6.2-G334D mutation does not influence nucleo-
tide handling by SUR1. Additionally, we assumed the same
value for L in all fits. L was calculated from a Po of 0.15 in
the absence of nucleotides. This is smaller than the Po of
0.375 0.07 reported for wild-type channels (33). However,
Po is extremely variable both between patches and between
preparations, probably due to channel rundown and other
variable biological processes. Furthermore, adjusting L is
reasonable as this parameter primarily determines the
magnitude of MgADP activation relative to the current in
the absence of nucleotide, which also varies widely among
different experiments (33,37–39). In terms of energetics, the
difference between the measured value (0.37) and our cho-
sen value (0.15) for Po is <1 kcal/mol. Finally, we assumed
that changes in macroscopic current were due to changes in
Po and not the number of channels (N). At the single-chan-Biophysical Journal 109(12) 2452–2460nel level, both MgADP and MgATP increased the Po of
Kir6.2-G334D/SUR1 by increasing the mean burst duration
and reducing the frequency and number of interburst closed
states (33).
Based on the increase in the single-channel Po of Kir6.2-
G334D/SUR1 channels elicited by saturating concentrations
of MgADP and MgATP (33), which was identical for both
nucleotides, we fixed the value of E, which reflects coupling
of the NBDs to the pore, at 9.5. To fit the activation-only
data (i.e., for Kir6.2-G334D/SUR1), we fixed K1 at 0 to
reflect a lack of binding to the inhibitory site. Therefore,
the only free parameter was the affinity constant K2. To
fit the inhibition-only data (i.e., for Kir6.2/SUR1 in Mg-
free solution), we fixed D at 106 because this provided
the best fit to the inhibition measured experimentally at
60 mMATP (33). K2 was set to 0 because there is no binding
to the NBDs in the absence of Mg2þ. Thus, the only free
parameter was K1.
We then used the values generated by fitting the activation-
only or inhibition-only curves to model the response of wild-
type channels to Mg-nucleotides. The only remaining free
parameter was F, which describes the direct interaction be-
tween the SUR1-activation sites and the Kir6.x-inhibitory
sites. We set F at 1 because varying it in either direction
caused the model to deviate substantially from the data for
MgADP activation.What does the model predict?
Although the model makes several simplifying assumptions,
it adequately describes the MgADP and MgATP sensitiv-
ities of Kir6.2/SUR1. We believe it may be useful as a heu-
ristic tool to understand the gating mechanism of KATP
channels. The model makes several predictions:
1) Based on both our model and the data reported in Proks
et al. (33), we propose that MgADP and MgATP activate
Kir6.2-G334D/SUR1 channels (and by implication
Kir6.2/SUR1 channels) to the same extent. Therefore,
the only difference in the activation-only curves is in
the affinity constants for the two nucleotides. The pre-
dicted K2 values are 5.7  104 M1 (KD ¼ 18 mM) for
MgADP and 3.93  103 M1 (KD ¼ 250 mM) for
MgATP. Thus, MgADP binds more tightly than MgATP
to one of the NBSs of SUR1 (most likely NBS2).
2) In wild-type channels, where both activation and inhibi-
tion are observed, MgADP produces a bell-shaped con-
centration-response curve, with distinct activation and
inhibition phases (33,37–39). In contrast, the MgATP
concentration-response curve resembles that obtained
for inhibition alone, with no apparent activation compo-
nent but a slightly greater Ki. This implies a limited role,
if any, for MgATP hydrolysis in direct channel gating.
This behavior is reproduced in our model and is a conse-
quence of the fact that MgATP has a lower affinity for
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FIGURE 3 Equilibrium gatingmodel of Kir6.2/SUR1. (A) Schematic representing the gating of KATP channels as three interacting domains: the pore, the inhib-
itoryNBSonKir6.2, and theNBSsofSUR1. (B)Gating scheme in (A) expanded intoa cubicmodel.CandOdesignate theclosedandopen states of theporedomain,
respectively.The subscripts designate the occupancyof the twoNBSs aseitherunbound (0) or nucleotide bound (A).Thefirst subscript refers to the inhibitory site on
Kir6.2 and the second refers to the NBDs. When both inhibition and activation by nucleotides are present, the open probability (Po) is described by
Po ¼
K1LDþ K2LEþ L½ANP þ K1K2LDEF½ANP
K1 þ K2 þ K1LDþ K2LEþ 1½ANP þ L½ANP þ K1K2F½ANP þ K1K2LDEF½ANP
;
(legend continued on next page)
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2456 Vedovato et al.the NBSs than does MgADP. At high nucleotide concen-
trations, where both the NBSs and the inhibitory binding
sites are occupied, inhibition dominates because of dif-
ferences in energetics. Based on the Proks et al. (33)
data and the fits from our model, nucleotide binding
to the inhibitory site stabilizes the closed state by
~8 kcal/mol, whereas binding to the NBSs only contrib-
utes ~1.3 kcal/mol to stabilize the open state.
3) The allosteric coupling between the NBSs and the inhib-
itory Kir6.2 binding site can be adequately explained by
the coupling of both domains to the pore, without the
need to invoke a direct, functional interaction between
the two (i.e., F ¼ 1). In other words, nucleotide binding
to SUR does not alter nucleotide binding to Kir6.2 (and
vice versa) except via changes in channel gating.
4) Hydrolysis of ATP at the NBDs is not required to explain
the differences in gating between ATP and ADP. Our
equilibrium model adequately represents the activation
of Kir6.2/SUR1 channels without including any irrevers-
ible hydrolysis steps. This suggests that binding of
MgATP (like MgADP) at NBS2 may directly promote
channel opening in Kir6.2/SUR1 channels.
5) In almost all studies published to date, the experimental
data were normalized in various ways to correct for
rundown, and we have taken this into account in our
modeling. If the rundown could be stabilized, however,
and the data expressed as actual Po rather than normal-
ized Po, the concentration-response curves for nucleotide
effects on macroscopic currents would contain informa-
tion regarding not only the concentration range over
which nucleotides have their effects but also the ener-
getic contributions that nucleotide activation or inhibi-
tion make to gating. This information would provide
greater insight into the mechanism(s) underlying nucle-
otide modulation and the effects of disease-causing mu-
tations in KATP channel subunits.How valid are the model assumptions/
predictions?
The main predictions of our model as they relate to Mg-
nucleotide activation (as in Kir6.2-G334D/SUR1 channels)
are shown in Fig. 3 D. As noted above, we made several
simplifying assumptions. Chief among these was to treatwhere [ANP] is the nucleotide concentration and all other symb
lines) fit to the nucleotide activation/inhibition data (open circles
normalized, the model was also normalized. For activation curv
(L/(L þ 1)) and dividing the difference by the maximum Po (EL
the equation was divided by the Po in the absence of nucleotide (L
the model was normalized to the Po in the absence of nucleotid
otide binding at SUR1. This schematic assumes that SUR1 can
channel activation by MgATP.
Biophysical Journal 109(12) 2452–2460the eight NBSs as a single unit with a single binding affinity
constant. However, the reported number of SUR subunits
required to activate KATP varies in the literature (40–42).
We also modeled the inhibitory ATP binding sites as a single
site, but this too is controversial (28,31). Therefore, we also
considered four alternatives (Fig. S1 in the Supporting Ma-
terial). We modeled the NBSs as four separate subunits with
cooperative binding and a concerted conformational change
(Fig. S1 A), four subunits with independent binding and
a concerted conformational change when all subunits are
occupied (Fig. S1 B), and a Monod-Wyman-Changeux-
type model in which binding to each subunit is independent
and each subunit makes an identical energetic contribution
to the pore domain (Fig. S1 C). We modeled the inhibitory
Kir6.2 binding sites in the same way in each of these three
models. We also fit the data with a mixed model in which the
inhibitory Kir6.2 binding site was a single site and the bind-
ing sites on SUR1 were treated as four individual subunits,
each with independent binding and gating contributions
(Fig. S1 D). None of the alternative models fit the data
sets as well as the model presented in Fig. 3 (compare
Fig. S2, A–C, and Table S1), with the exception of the mixed
model, which did not improve upon the fit to our initial
model (compare Figs. 3 C, S2 D, and Table S1). None of
the fits were improved by introducing terms to describe a
direct interaction between the NBDs and the inhibitory
binding sites (F).
The largest deviation between our simple allosteric model
(Fig. 3) and the data from Proks et al. (33) is in the fit to
wild-type channels at lower MgADP concentrations (1–
30 mM), where activation dominates. Importantly, none of
the alternative models improved on the fit over this concen-
tration range. Therefore, the relatively poor agreement with
the data is not a consequence of the simplifying assumption
that the NBDs are treated as a single binding site. This de-
viation may instead challenge our assumption that there is
no difference in the ability of SUR1 to stabilize the open
state of the channel in wild-type versus Kir6.2-G334D chan-
nels. Alternatively, it may simply result from biological
variability across experiments (33,37–39).
As noted above, none of our fits had more than one free
parameter. However, the values generated are only as accu-
rate as our initial assumptions regarding L, D, and E. The
value for E calculated from the single-channel open proba-
bility of Kir6.2-G334D/SUR1 channels in the absence andols are as described in the main text. (C) Cubic model (solid
) from Proks et al. (33). Because the experimental data were
es, this was achieved by subtracting the Po at 0 nucleotide
/(EL þ 1)) minus the unliganded Po. For inhibition curves,
/(Lþ 1)). When both activation and inhibition were present,
e. (D) Simplified scheme for KATP activation via Mg-nucle-
hydrolyze MgATP, but that hydrolysis is not necessary for
NBDs of SUR1 2457presence of Mg-nucleotides was 9.5 5 1 (5 SEM). We
found that varying E between 8.5 and 10.5 (equivalent to
E 5 SEM) only affected the value generated for K2 by
7%. Changing the value of D by 100-fold had only minor ef-
fects (<<1%) on the K1 values generated. Changing our es-
timate for Po (and therefore L) to that reported for wild-type
Kir6.2/SUR1 channels in the absence of nucleotide (0.37)
had more significant effects, increasing our estimates of
K1 by 35% and decreasing the K2 values generated from
our fits by a factor of 1.8. Therefore, although we believe
the major predictions of our model to be robust, some
caution should be used in trusting the absolute value of
the binding affinities it produces, unless Po can be closely
monitored or controlled throughout an experiment.What is the role of NBS1?
Our model does not discriminate between Mg-nucleotide
binding to NBS1 and NBS2, but it has been proposed that
nucleotide interactions with NBS2 primarily drive channel
opening (3,43,44). What, then, is the role of NBS1?
A solely structural role is suggested by CFTR, an ABC
transporter that is also a Cl-permeable ion channel. As is
the case in SUR1, NBS1 of CFTR is degenerate. In
CFTR, channel opening is initiated by binding of MgATP
to NBS2 and terminated by ATP hydrolysis at NBS2 (45).
In contrast, ATP stays bound to NBS1 for several gating
cycles (46,47). Thus, bound ATP at NBS1 of CFTR can
be considered a structural element that allows for dimeriza-
tion of the NBDs when NBS2 is occupied (48).
In contrast, the functional effect of nucleotide binding to
NBS1 of SUR1 is not completely understood. In part, this is
because no measurements of equilibrium nucleotide binding
exist. It is uncertain whether mutations in NBS1 influence
ATP binding (as they do 8-azido-[32P]ATP binding) (49),
and SUR2A appears to handle nucleotides differently
from SUR1 (or SUR2B) (50–52). Furthermore, ATP hydro-
lysis properties differ when measured for isolated NBDs,
SUR, or the whole KATP channel complex (23,53). Thus,
extrapolation from data obtained in isolated domains or sub-
units to KATP channel gating has to be treated cautiously.
Results from analyses of NBS1 mutations are inconclu-
sive. Mutation of the Walker A lysine in NBS1 (K719
in SUR1) reduced high-affinity labeling of 8-azido-
[a-32P]ATP (49), but it is unclear whether the same is
true of ATP binding. It is possible that this mutation does
not alter ATP binding, as it decreased ATP hydrolysis by
SUR1 without affecting the Km for ATP (53) and reduced
MgATP activation without affecting the EC50 (39).
Although the K719A mutation strikingly shifted the EC50
for MgADP activation (39), this may have been mediated
via an allosteric effect on NBS2, perhaps by preventing
NBD dimerization. Complete deletion of NBD1 produced
channels that were not activated by MgADP and were
either less stable at the plasma membrane or not correctlytrafficked (54). On balance, the available data suggest that
NBD1 of SUR1 has an important structural role, but its in-
fluence on channel activity remains obscure. If it is indeed
merely a necessary structural element, then what is being
measured in experiments, and in our model, may be occu-
pancy of NBS2.
Interestingly, mutation of theWalker A lysine (K707A) of
NBS1 of SUR2A had no effect on Mg-nucleotide activation
(52), which may support the idea that, in this case at least,
ATP handling at NBS1 does not influence channel activity.
Why the same mutation in SUR2B, which differs from
SUR2A only in its last 42 amino acids, prevents MgADP
activation is a puzzle.Is MgATP hydrolysis necessary for activation?
In our model, hydrolysis of MgATP is not required for chan-
nel activation, implying that both MgADP and MgATP can
promote channel activation simply by binding more tightly
to the active conformation of the NBDs. The act of hydroly-
sis per se is not necessary to promote channel opening, as
MgADP is able to activate. However, it remains a possibility
that MgATP must first be hydrolyzed to MgADP to activate
channels.
Numerous studies have shown that isolated NBD2 (and to
a lesser extent NBD1) of SUR1 and SUR2 can hydrolyze
ATP (25,43,50,53), as can SUR1 (53) and Kir6.2/SUR1
(23). In the case of Kir6.2/SUR2A, conditions that lock
the channel in a posthydrolytic state favor channel opening
(43). Orthovanadate, which occupies the same position as
the g-phosphate of ATP, inhibits ATPase activity and stim-
ulates channel opening in the presence of ATP. This suggests
that the MgADP$Pi state is able to stabilize channel open-
ing. Likewise, MgADP is able to stimulate channel opening.
It is worth noting, however, that the orthovanadate effect de-
velops much more slowly than direct activation of Kir6.2-
G334D/SUR1 by MgATP or MgADP. BeF, which arrests
the ATPase cycle in a prehydrolytic configuration, impairs
the ATPase activity of SUR1 and SUR2 (53,55) and reduces
Kir6.2/SUR2A channel opening produced by MgADP (43).
This suggests that the MgADP$BeF state, analogously to a
prehydrolytic ATP-bound state, does not induce channel
activity, but it does not necessarily imply that MgATP is un-
able to directly stimulate channel opening, perhaps by stabi-
lizing a state that resembles a posthydrolytic conformation
of the NBDs.
Mutation of the catalytic residues of NBS2 of SUR1 im-
pairs ATPase activity (53). If these mutations only prevent
hydrolysis, they would be expected to affect activation by
MgATP, but not MgADP. However, mutation of the Walker
A lysine or Walker B aspartate in NBS2 of SUR1 impairs
activation by both MgADP and MgATP (2,4,34); indeed,
it appears to have a larger effect on MgADP activation
(39). This raises the possibility that these mutations affect
either nucleotide binding directly or the conformationalBiophysical Journal 109(12) 2452–2460
2458 Vedovato et al.change that couples binding to activation. Thus, the catalytic
residues in the NBDs of SUR may have functional effects
beyond MgATP hydrolysis. Experiments in which SUR1
was expressed without Kir6.2 showed that binding of ATP
(or ATP analogs) under nonhydrolytic conditions (e.g., no
Mg2þ, catalytically dead mutations) was still competent
to cause a conformational change in SUR1 as assayed
by a change in glibenclamide affinity (56,57). Therefore,
although it seems likely that KATP channels can hydrolyze
MgATP, this may not be an absolute requirement for chan-
nel activation via SUR. In future studies, single-channel and
kinetic analyses could be used to identify KATP gating tran-
sitions that are not at equilibrium (e.g., irreversible hydroly-
sis steps), as has been demonstrated for CFTR (45).Interactions between nucleotide binding at SUR
and Kir6.x
The final question is whether or not there is a direct,
functional interaction between the NBDs of SUR1 and the
inhibitory site of Kir6.2. Numerous studies (58–63) have
proposed such an interaction, but there is little direct evi-
dence. Our model predicts that such an interaction is not
necessary to explain the data.
How, then, might nucleotide occupancy at the NBSs be
relayed to the pore? In the crystal structure of the ABC
transporter McJD (64), the first cytosolic loop of TMD1
(and TMD2) contacts both NBDs, whereas the second inter-
acts only with the NBD from the opposite monomer. It is
possible the corresponding cytosolic loops (4,7) in SUR
may form coupling helices that transmit conformational
changes in the NBSs (produced by nucleotide binding/acti-
vation) to the TMDs. Both the cytoplasmic N-terminal
(58,61,63) and C-terminal (60) regions of Kir6.2 have
been proposed to interact with SUR. Likewise, many re-
gions of SUR, including TMD0 of SUR1 (59), the loop con-
necting TMD0 to TMD1 of SUR1 (61), and the linker
between TMD2 and NBD2 of SUR2A (62), have been sug-
gested to modify gating of Kir6.2. To date, however, none of
these interacting regions have been shown to directly trans-
duce binding of Mg-nucleotides at SUR to gating changes at
Kir6.2.CONCLUSIONS
Although there has been much work on the structure and
function of the NBSs of SUR and how they regulate KATP
channel activity, our understanding is still far from com-
plete. This is in part because there are few experiments in
which nucleotide binding and ATPase activity have been
measured in the intact KATP channel complex. The available
results suggest that lack of Kir6.2, or the TMDs of SUR,
influences nucleotide handling by the NBSs (compare (23)
and (53)). Thus, it is hard to compare electrophysiolog-
ical and biochemical data directly. A further problem isBiophysical Journal 109(12) 2452–2460that SUR1 and SUR2 show differences in nucleotide
handling—again, why they do so remains unclear. Although
a high-resolution structure of the KATP channel, or even
SUR, will undoubtedly provide many novel insights, it is
unlikely to resolve the issue of precisely how MgATP bind-
ing/hydrolysis at NBS2 opens the channel. Functional data
on nucleotide handling will still be required. We look for-
ward to seeing how the results of such diverse approaches
will combine to elucidate the working of the KATP channel,
and hope that our (admittedly simple) model will provide
testable predictions for experiments to come.SUPPORTING MATERIAL
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